HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Clinical Data Acquires Adenosine Therapeutics.
-
Business Wire; Aug 5, 2008; 700+ Words
* Expands therapeutics pipeline with compounds in cardiology...today announced the acquisition of Adenosine Therapeutics, L.L.C., a developer of drug products...use patents relating to selective adenosine receptor modulators. In exchange...
-
-
United States: Clinical Data acquires Adenosine Therapeutics.
-
TendersInfo; Aug 7, 2008; 700+ Words
...announced the acquisition of Adenosine Therapeutics, L.L.C., a developer of drug products...patents relating to selective adenosine receptor modulators. In exchange...The acquisition of Adenosine Therapeutics significantly expands Clinical...
-
-
United States: Clinical Data announces acquisition of Adenosine Therapeutics.
-
TendersInfo; Aug 6, 2008; 700+ Words
...announced the acquisition of Adenosine Therapeutics, L.L.C., a developer of drug products...that in exchange for all of Adenosine's operating assets, it paid...The acquisition of Adenosine Therapeutics expands its PGxHealth Division...
-
-
Metabasis Therapeutics Announces New Patents
-
PR Newswire; Feb 26, 1998; 700+ Words
...Metabasis Therapeutics, Inc., a majority...key series of adenosine kinase inhibitors...Mexico, S.A. de C.V. in Toluca...Lemery, S.A. de C.V. in Mexico...CONTACT: Martha L. Hough of Gensia...Metabasis Therapeutics, Inc.; ST...
-
-
Research from R.A. Hodgson et al has provided new information about depression.
-
Biotech Week; Aug 26, 2009; 700+ Words
...4-dihydroxy-L-phenylalanine (L-Dopa)-induced...kg) inhibited L-Dopa-induced...and Experimental Therapeutics (Characterization...triazolo[1,5-c]pyrimidin-5...States, Kenilworth, Adenosine, Depression, Drugs...
-
-
Astellas Pharma net sales reached 678,848 million, an increase of 2.
-
M2 Presswire; Apr 28, 2006; 700+ Words
...increase of 2.(C)1994-2006 M2...selective A2A adenosine-receptor agonist, with CV Therapeutics. CV Therapeutics advanced CVT...Detailed P&L and investment...Research AB- CV Therapeutics Inc (CVT)- Daiichi...
-
-
Reports by Y.Z. Wu and co-researchers describe recent advances in cardiology.(Report)
-
Biotech Week; Sep 23, 2009; 700+ Words
...of lactate and adenosine release by 70...Experimental Therapeutics (The Late Na...of Palmitoyl-L-Carnitine to...Experimental Therapeutics, 2009;330...contact J.C. Shryock, Gilead...Palo Alto, Adenosine, Cardiology...
-
-
Three Studies Evaluating Electrophysiological Properties Of Ranolazine Presented at NASPE Scientific Sessions.
-
PR Newswire; May 15, 2003; 700+ Words
...Lin Wu, John C. Shryock, Yuan...ranolazine (10 microM/L) was added, these...Yejia Song, John C. Shryock, Yuan...to 30 microM/L) attenuated EADs...years. None of CV Therapeutics' products have...Tecadenoson, an A1-adenosine receptor agonist...
-
-
StockGuru Price and Volume Alerts for Tuesday August 1, 2006 - One Company Makes Changes in the Board of Directors While Another Announces Letter of Agreement.
-
M2 Presswire; Aug 1, 2006; 700+ Words
...Agreement(C)1994...include Duska Therapeutics, Inc...200. Duska Therapeutics, Inc. a...based on adenosine 5'-triphosphate...Michael L. Babich...Company. Duska Therapeutics, Inc...related to adenosine 5'-triphosphate...
-
-
Drugs, methods poised to change imaging.(Cardiovascular Medicine)
-
Internal Medicine News; Feb 1, 2005; ; 700+ Words
...Hyperemia Drugs Adenosine and dipyridamole...according to Robert C. Hendel, M...effects caused by adenosine and dipyridamole...developed by CV Therapeutics Inc. A third...concordance with adenosine" for myocardial...BY MITCHEL L. ZOLER Philadelphia...
-
-
Circulation Publishes Study of Ranolazine Demonstrating Important Cardiac Ion Channel Effects.
-
PR Newswire; Aug 24, 2004; 700+ Words
...NA, Belardinelli L, Sabbah HN. Ranolazine...1068-128 -- Wu L, Shryock JC, Song...Y, Antzelevitch C, Belardinelli L. Anti-Arrhythmic...United States. CV Therapeutics is a development...a selective A2A-adenosine receptor agonist...
-
-
ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.(Research article)(positive transcription elongation factor b )(protein kinase c)(Report)
-
BMC Cancer; Feb 20, 2009; ; 700+ Words
...Dianne L Newton (corresponding...1]. As an adenosine analog, ARC...with related adenosine analogs. Results...protein kinase C (PKC) and...Developmental Therapeutics Program, National...degrees]C. All cell...100 [mu]L were placed...
-
-
EUROPEAN PATENT DISCLOSURES.
-
BIOWORLD Today; Oct 19, 2000; 700+ Words
...diagnostics and therapeutics. Altmann, F...WO 00/49051 Adenosine receptor antibodies...of the human adenosine A2B receptor...for generating therapeutics. Beth Israel...Vancouver, B.C. Caulobacter...Faustman, D.L. WO 00/48462...
-
-
Emerging Markets Consulting, LLC. : Emerging Equity Alerts.
-
M2 Presswire; Aug 25, 2008; 700+ Words
...Equity Alerts(C)1994-2008...water soluble therapeutics for poultry...known as A.L. Laboratories...manufacture and market adenosine-based products...intravenous solution of adenosine administered...sterile solution of adenosine administered...
-
-
Research on pharmacodynamics discussed by S.D. Kim and co-researchers.(Report)
-
Blood Weekly; Jul 9, 2009; 700+ Words
...10-rho mol/L adenosine diphosphate was...mean values for C and AUC(0...mean values for C AUC(0-t...transformed C-max, AUC...research in Clinical Therapeutics (Bioequivalence...South Korea, Adenosine, Angiology...
-
-
Guru Alerts for Thursday, May 11, 2006 NCSH, APHY, HSTT, DLTM, DSKT.
-
M2 Presswire; May 11, 2006; 700+ Words
...DLTM), and Duska Therapeutics, Inc. (OTCBB: DSKT...venture with TPG Partners, L.L.C. Assured Pharmacy was...deltamutual.comDuska Therapeutics, Inc. (OTCBB: DSKT...therapeutic products related to adenosine 5'-triphosphate...
-
-
Enzon Reports Solid First Quarter; New Corporate Strategy Begins to Deliver Results.
-
Business Wire; May 2, 2006; 700+ Words
...shares of Nektar Therapeutics, Inc. (Nektar...version of the enzyme L-asparaginase used...arabinoside or ara-C used for the treatment...competition from new therapeutics entering the market...therapy used to treat adenosine deaminase (ADA...
-
-
(ENZN) SqueezeTrigger Price is $8.160. There is $52,540,584.64 That Short Sellers Still Need To Cover.
-
M2 Presswire; Sep 29, 2009; 700+ Words
...Sellers Still Need To Cover(C)1994-2009 M2 COMMUNICATIONS...versions of injectable therapeutics through the chemical attachment...chronic deficiency of the adenosine deaminase enzyme (ADA...occurring enzyme called L-asparaginase. The product...
-
-
(ENZN) SqueezeTrigger Price is $8.160. There is $52,284,601.28 That Short Sellers Still Need To Cover.
-
M2 Presswire; Sep 28, 2009; 700+ Words
...Sellers Still Need To Cover(C)1994-2009 M2 COMMUNICATIONS...versions of injectable therapeutics through the chemical attachment...chronic deficiency of the adenosine deaminase enzyme (ADA...occurring enzyme called L-asparaginase. The product...
-
-
(ENZN) SqueezeTrigger Price is $8.164. There is $90,842,230.00 That Short Sellers Still Need To Cover.
-
M2 Presswire; Aug 31, 2007; 700+ Words
...Sellers Still Need To Cover(C)1994-2007 M2 COMMUNICATIONS...versions of injectable therapeutics through the chemical attachment...chronic deficiency of the adenosine deaminase enzyme (ADA...occurring enzyme called L-asparaginase. The product...
|
|